Study identifies malaria resistance genes, possible drug targets
A new study of drug resistance in the parasite responsible for roughly half of all malaria cases worldwide has identified more than 80 genes that contribute to resistance, some of which could provide important information for drug development, researchers say.
[…]In recent years, however, a strain of P falciparum resistant to artemisinin and its partner drug piperaquine has begun to emerge in the countries of the Greater Mekong subregion—Cambodia, Laos, Myanmar, Thailand, and Vietnam.
Chris Dall
